Year 2019,
Volume: 5 Issue: 1, 95 - 96, 01.01.2019
Abstract
Among the all psycho-dermatologic associations, one of the most discussed topics is the striking relationship between psoriasis and schizophrenia. There are multiple controlled trials as well as meta-analyses on this subject and interesting theories have been developed. We are trying to compile and concise the available information and to present it in a structured way for better understanding, through this letter.
Keywords
References
- Debnath M, Berk M. Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications. Schizophr Bull 2014;40:1412–1421.
- Di Nuzzo S, Zanni M, De Panfilis G. Exacerbation of paranoid schizophrenia in a psoriatic patient after treatment with cyclosporine A, but not with etanercept. J Drugs Dermatol 2007;6:1046–1047.
- Riedmuller R, Muller S. Ethical implications of the mild encephalitis hypothesis of schizophrenia. Front Psychiatry 2017;8:38.
- Yang YW, Lin HC. Increased risk of psoriasis among patients with schizophrenia: a nationwide population-based study. Br J Dermatol 2012;166:899–900.
- Ungprasert P, Wijarnpreecha K, Cheungpasitporn W. Patients with schizophrenia have a higher risk of psoriasis: A systematic review and meta-analysis. Psychiatry Research 2018;259:422–426.
- Kumar V, Mattoo SM, Handa S. Psychiatric morbidity in pemphigus and psoriasis: a comparative study from India. Asian J Psychiatry 2013;6:151–156.
- Miyaoka T, Seno H, Inagaki T, et al. Schizophrenia associated with psoriasis vulgaris: three case reports. Schizophr Res 2000;41:383–386.
- Shimamoto Y, Shimamoto H. Annular pustular psoriasis associated with affective psychosis. Cutis 1990;45:439–442.
- Latini A, Carducci M. Psoriasis during therapy with olanzapine. Eur J Dermatol 2003;13:404–405.
- Ascari-Raccagni A, Baldari U, Rossi E, Alessandrini F. Exacerbation of chronic large plaque psoriasis associated with Olanzepine therapy. J Eur Acad Dermatol Venereol 2000;14:315–316.
- Kaufman KR. Etanercept, anticytokines and mania. Int Clin Psychopharmacol 2005;20:239–241. How to cite?
Year 2019,
Volume: 5 Issue: 1, 95 - 96, 01.01.2019
Abstract
References
- Debnath M, Berk M. Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications. Schizophr Bull 2014;40:1412–1421.
- Di Nuzzo S, Zanni M, De Panfilis G. Exacerbation of paranoid schizophrenia in a psoriatic patient after treatment with cyclosporine A, but not with etanercept. J Drugs Dermatol 2007;6:1046–1047.
- Riedmuller R, Muller S. Ethical implications of the mild encephalitis hypothesis of schizophrenia. Front Psychiatry 2017;8:38.
- Yang YW, Lin HC. Increased risk of psoriasis among patients with schizophrenia: a nationwide population-based study. Br J Dermatol 2012;166:899–900.
- Ungprasert P, Wijarnpreecha K, Cheungpasitporn W. Patients with schizophrenia have a higher risk of psoriasis: A systematic review and meta-analysis. Psychiatry Research 2018;259:422–426.
- Kumar V, Mattoo SM, Handa S. Psychiatric morbidity in pemphigus and psoriasis: a comparative study from India. Asian J Psychiatry 2013;6:151–156.
- Miyaoka T, Seno H, Inagaki T, et al. Schizophrenia associated with psoriasis vulgaris: three case reports. Schizophr Res 2000;41:383–386.
- Shimamoto Y, Shimamoto H. Annular pustular psoriasis associated with affective psychosis. Cutis 1990;45:439–442.
- Latini A, Carducci M. Psoriasis during therapy with olanzapine. Eur J Dermatol 2003;13:404–405.
- Ascari-Raccagni A, Baldari U, Rossi E, Alessandrini F. Exacerbation of chronic large plaque psoriasis associated with Olanzepine therapy. J Eur Acad Dermatol Venereol 2000;14:315–316.
- Kaufman KR. Etanercept, anticytokines and mania. Int Clin Psychopharmacol 2005;20:239–241. How to cite?
There are 11 citations in total.
Details
| Primary Language | English |
|---|---|
| Journal Section | Research Article |
| Authors | |
| Publication Date | January 1, 2019 |
| Published in Issue | Year 2019 Volume: 5 Issue: 1 |